Pharmaceutical Technology, Nov 2, 2008 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Nov 2, 2008
Online Exclusive
Bringing Certainties to a Burgeoning Field
By Theodore H. Meltzer
A well-balanced guide to industrial bioseparations provides valuable information.
Report from: India
By A. Nair
The Indian government may soon monopolize its pharmaceutical industry to cut costs and improve healthcare, but the move is sounding off alarm bells with the companies whose drug products are under review.
FDA Collaborates on Nanotechnology Research
By Jill Wechsler
The US Food and Drug Administration seeks to understand nanotechnology better and exercise appropriate oversight over products that incorporate it.
IPEC's New Safety Evaluation Procedure: A Q&A with IPEC Chairman Dave Schoneker
By Maribel Rios
IPEC Chairman Dave Schoneker discusses current efforts toward facilitating regulatory reviews of new excipients.
Special Report
A Fresh Coat: Innovation in Excipients
By Maribel Rios
Sophisticated excipient development, especially for coatings, is staying on top of new challenges and meeting expanding industry needs.
Peer-Reviewed Research
Orally Disintegrating Tablets
By S. Kruse , S. Gebert , K. Meyer-Böhm , A. Maschke, PhD , K. Kolter, PhD
The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
The Effect of Mill Type on Two Dry-Granulated Placebo Formulations
By Thomas A. Vendola , Bruno C. Hancock
The authors evaluate the effect of various mill types on particle-size distribution, flowability, tabletability, and compactibility.
Dendrimers and Topical Drug Delivery
By Gaurav T. Tolia , Hannah H. Choi, PhD
This review provides an update of how dendrimer technology is being applied to the development of novel systems for various topical delivery applications.
Articles
Science and Technology of Bioadhesive-Based Targeted Oral Delivery Systems
By Avinash Nangia, PhD
Novel hydrophobic bioadhesive polymers and dosage designs are now available to effectively achieve tailored release kinetics of a broad range of drugs to meet the clinical needs.
Ingredients Insider
Exploring Solid-State Chemistry
By Patricia Van Arnum
Optimizing the solid form of a drug reaps scientific and technical awards.
Position Papers
The Ideal Pharmacopeia
By J. Mark Wiggins , Janeen A. Skutnik , Judy L. Shimek-Cox , Neil A. Schwarzwalder
This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.
Outsourcing Outlook
Leading European CMOs Consolidate Market Positions
By Jim Miller
Despite challenges, contract manufacturers in Europe are enjoying considerable success.
Washington Report
Nanotechnology Challenges FDA and Manufacturers
By Jill Wechsler
Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
Agent-In-Place
Holey Smoked Fish Flakes!
By Control, a senior compliance officer
Production problems come in all shapes, sizes, and ... species.
Inside USP
Inside USP: USP Metals Testing: A Workshop Report
By Stefan Schuber, PhD , Anthony J. DeStefano, PhD , Roger L. Williams , William F. Koch , Darrell R. Abernethy
Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Viewpoint
RFID versus Barcode
By Ray Cronin
Data capture needs to be fast and reliable...so which automatic identification technology is best?
From The Editor
Quality Counts
By Michelle Hoffman
Pharma companies could benefit from the lessons learned in this fall's financial crisis.
PharmTech Talk
Bringing AAPS to You
By Patricia Van Arnum
Pharmaceutical Technology will feature video coverage of AAPS this month.
News
Report From: China
By Jane Wan
With government support, China's pharmaceutical equipment sector is trekking ahead despite challenges regarding the country's overall perceived product quality.
Coming Down the Pike: Chaperones
By Michelle Hoffman
Molecules called "chaperones" facilitate correct protein folding.
Trends In: FDA Enforcement Actions
By Angie Drakulich
Trends In: Foreign Inspections
By Angie Drakulich
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations
Pharma Capsules
Pharma Capsules
Brief pharmaceutical news items for November 2008.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here